Xinkui P. Liu
Beijing, 100048, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
The clinical research of IFNGR1 proximal promoter polymorphism in susceptibility and prognosis of breast cancer
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: July 15, 2025
PTPRG-AS1 regulates the KITLG/KIT pathway through the ceRNA axis to promote the malignant progression of gastric cancer and the intervention effect of Compound Kushen injection on it.
Journal: Pharmacological research
Published: March 06, 2025
Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019.
Journal: Medicine
Published: September 01, 2023
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.
Journal: Computers in biology and medicine
Published: April 12, 2023
T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing.
Journal: Computers in biology and medicine
Published: October 20, 2022
Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Journal: Scientific reports
Published: October 09, 2022
Lactoferrin Alleviates Lipopolysaccharide-Induced Infantile Intestinal Immune Barrier Damage by Regulating an ELAVL1-Related Signaling Pathway.
Journal: International journal of molecular sciences
Published: September 30, 2022
Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease.
Journal: Medicine
Published: September 10, 2022
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
Journal: Frontiers in immunology
Published: June 09, 2022
Last Updated: 09/26/2026